Efficacy and Cerebrospinal Fluid Rhinorrhea after Cabergoline Treatment in Patients with Bioactive Macroprolactinoma
Predicting dopamine agonist resistance in patients with macroprolactinoma is essential for clinicians to prevent treatment failure and subsequent complications such as medication-induced cerebrospinal fluid (CSF) rhinorrhea. We evaluated the features of patients with cabergoline resistance and CSF r...
Saved in:
Main Authors: | Hae-Kyung Kim, Jae-Won Hong, Ju-Hyung Moon, Sung-Soo Ahn, Eui-Hyun Kim, Seung-Koo Lee, Eun-Jig Lee, Yae-Won Park, Cheol-Ryong Ku |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/e9510b45db974f3390a6d6e6d2b51516 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Reducing the risk of cerebrospinal fluid rhinorrhea following translabyrinthine surgery of the posterior fossa
by: Matthew W. Cooper, et al.
Published: (2021) -
Macroprolactinoma en adolescentes: respuesta al tratamiento con bromocriptina
by: Reyes G,Maria Loreto, et al.
Published: (1996) -
Effects of Pituitary Surgery and High-Dose Cabergoline Therapy on Metabolic Profile in Patients With Prolactinoma Resistant to Conventional Cabergoline Treatment
by: Rosa Pirchio, et al.
Published: (2021) -
Resultados visuales en pacientes con macroprolactinoma tratados con agonistas de dopamina
by: Cuevas,José Luis, et al.
Published: (2013) -
The recurrence of prolactinoma after withdrawal of dopamine agonist: a systematic review and meta-analysis
by: Yunzhi Zou, et al.
Published: (2021)